Connect Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.

About CNTB

Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. 

CEO
Zheng Wei
CEOZheng Wei
Employees
81
Employees81
Headquarters
Taicang, Jiangsu
HeadquartersTaicang, Jiangsu
Founded
2015
Founded2015
Employees
81
Employees81

CNTB Key Statistics

Market cap
75.05M
Market cap75.05M
Price-Earnings ratio
-0.86
Price-Earnings ratio-0.86
Dividend yield
—
Dividend yield—
Average volume
75.18K
Average volume75.18K
High today
$1.36
High today$1.36
Low today
$1.30
Low today$1.30
Open price
$1.30
Open price$1.30
Volume
13.82K
Volume13.82K
52 Week high
$2.84
52 Week high$2.84
52 Week low
$0.5347
52 Week low$0.5347
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.